Oruka Therapeutics, Inc. ($ORKA)
Filing Information
| Accession Number | 0000907654-26-000110 |
|---|---|
| Form Type | 4 |
| Filing Date | Oct 21, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
27,000
Total Value
$776,934.83
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
General Counsel | Common Stock | โ | Oct 20, 2026 | Exercise/Conversion | 9,000 | $7.80 | $70,200.00 | 38,995 | Direct | โ | View Details | |
General Counsel | Common Stock | โ | Oct 20, 2026 | Sale | 400 | $74.90 | $29,960.28 | 38,595 | Direct | โ | View Details | |
General Counsel | Common Stock | โ | Oct 20, 2026 | Sale | 500 | $76.12 | $38,059.00 | 38,095 | Direct | โ | View Details | |
General Counsel | Common Stock | โ | Oct 20, 2026 | Sale | 1,000 | $77.20 | $77,205.00 | 37,095 | Direct | โ | View Details | |
General Counsel | Common Stock | โ | Oct 20, 2026 | Sale | 4,100 | $78.79 | $323,036.95 | 32,995 | Direct | โ | View Details | |
General Counsel | Common Stock | โ | Oct 20, 2026 | Sale | 3,000 | $79.49 | $238,473.60 | 29,995 | Direct | โ | View Details | |
General Counsel | Employee Warrant (right to buy) | Derivative | Oct 20, 2026 | Exercise/Conversion | 9,000 | $0.00 | $0.00 | 70,996 | Direct | โ | View Details |